Carotid intima-media thickness and left ventricular hypertrophy in hemodialysis patients

Mahmoud Rafieian-Kopaei1, Hamid Nasri2

  • 1Medical Plants Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran.

Insights

Cardiovascular disease in hemodialysis patients is linked to left ventricular hypertrophy (LVH) and intima-media thickening (IMT). Higher LVH stages correlate with longer hemodialysis, hypertension, and IMT, especially in diabetics.

Area of Science:

  • Cardiology
  • Nephrology
  • Vascular Biology

Background:

  • End-stage renal disease (ESRD) patients on hemodialysis commonly exhibit cardiovascular issues.
  • Key findings include left ventricular hypertrophy (LVH) and arterial disease, characterized by intima-media complex thickening (IMT).

Purpose of the Study:

  • To investigate the relationship between left ventricular hypertrophy (LVH) and intima-media complex thickening (IMT).
  • Focus on end-stage renal disease (ESRD) patients undergoing regular hemodialysis.

Main Methods:

  • Studied 61 ESRD patients on maintenance hemodialysis (50 non-diabetic, 11 diabetic).
  • Utilized echocardiography and B-mode ultrasonography to measure carotid intima-media thickness (IMT).

Main Results:

  • Positive correlation found between LVH stages and hemodialysis duration, hypertension (HTN) stages, and carotid IMT.
  • LVH correlated with chest pain; diabetic patients showed greater IMT. Diabetes was linked to chest pain.
  • Hypertension stages correlated with IMT; IMT showed a reverse correlation with cardiac ejection fraction.

Conclusions:

  • Intima-media complex thickening (IMT) is more prevalent in hemodialysis subjects with left ventricular hypertrophy (LVH).
  • The severity of IMT is comparable to LVH severity when LVH is present.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
789
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.4K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
2.1K
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
3.8K